$CBDY
Target Group Inc. Stock $cbdy

$cbdy Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000141057822000428 Filed on March 18, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change		-100.0%
Gross Profit	$0.00	$0.00	$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$111.9K	$1.039M	$214.5K
YoY Change	-47.83%	-13.95%	-79.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$240.4K	$971.5K	$230.3K
YoY Change	4.39%	231.64%	2430.55%
% of Gross Profit
Operating Expenses	$208.1K	$1.350M	$444.7K
YoY Change	-53.21%	-14.0%	-61.39%
Operating Profit	-$208.1K	-$1.350M	-$444.7K
YoY Change	-53.21%	-13.72%
Interest Expense	$133.3K	$985.6K	-$406.8K
YoY Change	-132.76%	91.75%	-34.0%
% of Operating Profit
Other Income/Expense, Net	$14.48K	$1.623M	-$15.13K
YoY Change	-195.7%	-129.45%	-156.67%
Pretax Income	-$60.64K	$272.9K	-$5.361M
YoY Change	-98.87%	-103.86%	-11.35%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$60.64K	$272.9K	-$5.361M
YoY Change	-98.87%	-103.86%	-11.57%
Net Earnings / Revenue
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	-$98.39	$0.00	-$9.350K
COMMON SHARES
Basic Shares Outstanding	616.7M	595.3M
Diluted Shares Outstanding		595.3M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$113.1K	$113.1K	$172.6K
YoY Change	-34.48%	-34.48%	1545.38%
Cash & Equivalents	$122.2K		$181.6K
Short-Term Investments
Other Short-Term Assets	$344.5K	$344.5K	$327.0K
YoY Change	5.35%	5.35%	767.37%
Inventory	$99.00K	$99.00K	$99.00K
Prepaid Expenses	$44.57K		$46.78K
Receivables	$2.068K	$2.070K	$2.068K
Other Receivables	$25.58K	$25.58K	$154.0K
Total Short-Term Assets	$584.2K	$584.2K	$754.7K
YoY Change	-22.58%	-22.59%	254.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.842M	$6.926M	$7.794M
YoY Change	-12.22%	-12.26%	-3.82%
Goodwill	$3.682M		$3.666M
YoY Change	0.43%
Intangibles
YoY Change
Long-Term Investments	$1.870M	$1.870M	$721.2K
YoY Change	159.32%	159.32%
Other Assets
YoY Change
Total Long-Term Assets	$12.48M	$12.48M	$12.28M
YoY Change	1.6%	1.6%	-24.43%
TOTAL ASSETS
Total Short-Term Assets	$584.2K	$584.2K	$754.7K
Total Long-Term Assets	$12.48M	$12.48M	$12.28M
Total Assets	$13.06M	$13.06M	$13.04M
YoY Change	0.2%	0.2%	-20.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.200M	$1.200M	$2.974M
YoY Change	-59.64%	-59.64%	588.87%
Accrued Expenses	$2.027M	$2.027M	$1.489M
YoY Change	36.1%	36.1%
Deferred Revenue			$42.72K
YoY Change
Short-Term Debt	$990.00	$990.00	$4.690K
YoY Change	-78.89%	-78.89%	-99.11%
Long-Term Debt Due	$601.6K
YoY Change
Total Short-Term Liabilities	$4.043M	$4.043M	$4.873M
YoY Change	-17.03%	-17.03%	-5.09%
LONG-TERM LIABILITIES
Long-Term Debt	$7.760M	$9.622M	$7.103M
YoY Change	9.24%	35.45%	14816.69%
Other Long-Term Liabilities	$1.550M	$1.550M	$4.581M
YoY Change	-66.16%	-66.16%	-38.86%
Total Long-Term Liabilities	$11.17M	$11.17M	$11.68M
YoY Change	-4.39%	-4.39%	54.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.043M	$4.043M	$4.873M
Total Long-Term Liabilities	$11.17M	$11.17M	$11.68M
Total Liabilities	$15.22M	$15.22M	$16.56M
YoY Change	-8.11%	-8.11%	30.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.26M		-$26.54M
YoY Change	-1.03%
Common Stock	$61.70K		$57.33K
YoY Change	7.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.152M	-$2.152M	-$3.521M
YoY Change
Total Liabilities & Shareholders Equity	$13.06M	$13.06M	$13.04M
YoY Change	0.2%	0.2%	-20.82%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$60.64K	$272.9K	-$5.361M
YoY Change	-98.87%	-103.86%	-11.57%
Depreciation, Depletion And Amortization	$240.4K	$971.5K	$230.3K
YoY Change	4.39%	231.64%	2430.55%
Cash From Operating Activities	$608.0K	$100.1K	-$213.4K
YoY Change	-384.93%	-106.99%	153.29%
INVESTING ACTIVITIES
Capital Expenditures			$120.00
YoY Change			-100.07%
Acquisitions
YoY Change
Other Investing Activities	-$486.4K	-$1.406M	-$364.0K
YoY Change	33.63%	50.56%	-2836.69%
Cash From Investing Activities	-$482.5K	-$1.406M	-$363.9K
YoY Change	32.6%	44.0%	120.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-41.51K	1.251M	29.17K
YoY Change	-242.3%	-51.34%	-90.66%
NET CHANGE
Cash From Operating Activities	608.0K	100.1K	-213.4K
Cash From Investing Activities	-482.5K	-1.406M	-363.9K
Cash From Financing Activities	-41.51K	1.251M	29.17K
Net Change In Cash	83.98K	-54.36K	-548.1K
YoY Change	-115.32%	-133.5%	-968.42%
FREE CASH FLOW
Cash From Operating Activities	$608.0K	$100.1K	-$213.4K
Capital Expenditures			$120.00
Free Cash Flow			-$213.5K
YoY Change			-327.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3128
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7902
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12068
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4043257
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4873428
CY2020Q4	cbdy	Settlement Liabilities Non Current SettlementLiabilitiesNonCurrent	10000
CY2021Q4	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	9621696
CY2020Q4	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	7103325
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1528033
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1622366
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	22095
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2948823
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	971524
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	292944
CY2021	cbdy	Operating Lease Income Expense OperatingLeaseIncomeExpense	-1761
CY2020	cbdy	Operating Lease Income Expense OperatingLeaseIncomeExpense	-130180
CY2021	cbdy	General And Administrative Income Expense GeneralAndAdministrativeIncomeExpense	17991
CY2020	cbdy	General And Administrative Income Expense GeneralAndAdministrativeIncomeExpense	-136462
CY2021	us-gaap	Operating Expenses OperatingExpenses	1349695
CY2020	us-gaap	Operating Expenses OperatingExpenses	1569377
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2930894
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3228622
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	26049
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-168034
CY2020	us-gaap	Accretion Expense AccretionExpense	27704
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30769
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	7880
CY2021	cbdy	Allowance For Sales Tax Recoverable AllowanceForSalesTaxRecoverable	19453
CY2020	cbdy	Allowance For Sales Tax Recoverable AllowanceForSalesTaxRecoverable	-7119
CY2020	cbdy	Impairment Of Goodwill ImpairmentOfGoodwill	4413742
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272995
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-248685
CY2021	cbdy	Debt Issuance Costs DebtIssuanceCosts	52797
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0005
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0125
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	595347680
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	566883437
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001586554
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Trading Symbol TradingSymbol	CBDY
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2020Q4	us-gaap	Goodwill Goodwill	3666364
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84618
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	100548
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	000-55066
CY2021	dei	Entity Registrant Name EntityRegistrantName	TARGET GROUP INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3621499
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	20 Hempstead DriveHamilton
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
CY2021	dei	Entity Address Country EntityAddressCountry	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L8W 2E7
CY2021	dei	City Area Code CityAreaCode	+1 905
CY2021	dei	Local Phone Number LocalPhoneNumber	541-3833
CY2021	dei	Security12g Title Security12gTitle	Common Stock, Par Value $0.0001
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	14824053
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	617025999
CY2021	dei	Auditor Firm AuditorFirmId	5525
CY2021	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2021Q4	us-gaap	Cash Cash	113079
CY2020Q4	us-gaap	Cash Cash	172597
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	9072
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	9032
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2068
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2068
CY2021Q4	us-gaap	Inventory Net InventoryNet	99000
CY2020Q4	us-gaap	Inventory Net InventoryNet	99000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44567
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	46775
CY2021Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	21637
CY2020Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	75462
CY2021Q4	us-gaap	Due From Joint Ventures Current DueFromJointVenturesCurrent	290855
CY2020Q4	us-gaap	Due From Joint Ventures Current DueFromJointVenturesCurrent	271184
CY2021Q4	us-gaap	Other Receivables OtherReceivables	3944
CY2020Q4	us-gaap	Other Receivables OtherReceivables	78540
CY2021Q4	us-gaap	Assets Current AssetsCurrent	584222
CY2020Q4	us-gaap	Assets Current AssetsCurrent	754658
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6841770
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7793997
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1870123
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	721156
CY2021Q4	us-gaap	Goodwill Goodwill	3682236
CY2020	cbdy	Debt Issuance Costs DebtIssuanceCosts	19054
CY2020Q4	cbdy	Shares To Be Issued Total SharesToBeIssuedTotal	192121
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	12478747
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	12282065
CY2021Q4	us-gaap	Assets Assets	13062969
CY2020Q4	us-gaap	Assets Assets	13036723
CY2021Q4	us-gaap	Bank Overdrafts BankOverdrafts	506
CY2020Q4	us-gaap	Bank Overdrafts BankOverdrafts	1562
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2885909
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1809120
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	42719
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	10000
CY2020Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	90000
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1037104
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2831635
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	101356
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83196
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	480
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11171824
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11684514
CY2021Q4	us-gaap	Liabilities Liabilities	15215081
CY2020Q4	us-gaap	Liabilities Liabilities	16557942
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	617025999
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	573277094
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	61703
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	57328
CY2021Q4	cbdy	Shares To Be Issued Total SharesToBeIssuedTotal	174722
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1622576
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3347630
CY2021	us-gaap	Interest Expense InterestExpense	985634
CY2020	us-gaap	Interest Expense InterestExpense	514028
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-73163
CY2020	us-gaap	Management Fee Expense ManagementFeeExpense	286978
CY2021	cbdy	Salary And Wage Nonofficer SalaryAndWageNonofficer	9271
CY2020	cbdy	Salary And Wage Nonofficer SalaryAndWageNonofficer	-175509
CY2021	us-gaap	Legal Fees LegalFees	232151
CY2020	us-gaap	Legal Fees LegalFees	477539
CY2020	cbdy	Advertising And Promotion AdvertisingAndPromotion	299
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24985697
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23940696
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26263614
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26536495
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1110720
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1174969
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2152112
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3521219
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13062969
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13036723
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	25000
CY2020	us-gaap	Gross Profit GrossProfit	5000
CY2021	us-gaap	Professional Fees ProfessionalFees	21702
CY2020	us-gaap	Professional Fees ProfessionalFees	69466
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	149819
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1417751
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	337130
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7351763
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0005
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0125
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5509494
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	272881
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7073871
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Net Income Loss NetIncomeLoss	272881
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-7073871
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	64249
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	595347680
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-277892
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	566883437
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3521219
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2648
CY2021	cbdy	Shares To Be Issued As Compensation To Intellectual Property Rights Value SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue	1294
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1027807
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	228
CY2021	us-gaap	Net Income Loss NetIncomeLoss	272881
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	64249
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2152112
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3789021
CY2020	cbdy	Shares To Be Issued As Compensation To Intellectual Property Rights Value SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue	803
CY2020	cbdy	Execution Of Settlement Agreement ExecutionOfSettlementAgreement	260050
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	40770
CY2020	cbdy	Shares And Warrants Issued Value Pursuant To Debt Purchase And Assignment Agreement SharesAndWarrantsIssuedValuePursuantToDebtPurchaseAndAssignmentAgreement	260000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-7073871
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-277892
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3521219
CY2021	us-gaap	Profit Loss ProfitLoss	272881
CY2020	us-gaap	Profit Loss ProfitLoss	-7073871
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2930894
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3228622
CY2021	cbdy	Net Gain Loss On Settlement Of Liability NetGainLossOnSettlementOfLiability	26049
CY2020	cbdy	Net Gain Loss On Settlement Of Liability NetGainLossOnSettlementOfLiability	-3347630
CY2020	us-gaap	Accretion Expense AccretionExpense	27704
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4969
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	5781
CY2021	cbdy	Allowance For Sales Tax Recoverable AllowanceForSalesTaxRecoverable	19453
CY2020	cbdy	Allowance For Sales Tax Recoverable AllowanceForSalesTaxRecoverable	-7119
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	971524
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	292944
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	266757
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	289083
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-272995
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-248685
CY2021	cbdy	Debt Issuance Costs DebtIssuanceCosts	52797
CY2020	cbdy	Debt Issuance Costs DebtIssuanceCosts	19054
CY2020	cbdy	Impairment Of Goodwill ImpairmentOfGoodwill	4413742
CY2020	us-gaap	Increase Decrease In Inventories And Other Operating Assets IncreaseDecreaseInInventoriesAndOtherOperatingAssets	-25000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2400
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7982
CY2021	cbdy	Increase Decrease In Sales Tax Recoverable IncreaseDecreaseInSalesTaxRecoverable	73471
CY2020	cbdy	Increase Decrease In Sales Tax Recoverable IncreaseDecreaseInSalesTaxRecoverable	-43382
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-74751
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	74620
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">CONCENTRATION OF RISK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high-quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of December 31, 2021 and 2020.</p>
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	642242
CY2021	cbdy	Change In Operating Lease Liability Net ChangeInOperatingLeaseLiabilityNet	333782
CY2020	cbdy	Change In Operating Lease Liability Net ChangeInOperatingLeaseLiabilityNet	323676
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	100118
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1433169
CY2021	cbdy	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	-11876
CY2020	cbdy	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	42505
CY2021	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	1417842
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	933850
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1405966
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-976355
CY2021	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-1058
CY2020	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-43001
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	314740
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3467676
CY2020	cbdy	Payments To Long Term Loans To Related Parties PaymentsToLongTermLoansToRelatedParties	249978
CY2020	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-221693
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1027807
CY2021	cbdy	Payment For Settlement Payable PaymentForSettlementPayable	90000
CY2020	cbdy	Payment For Settlement Payable PaymentForSettlementPayable	130000
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	251213
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1251489
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2571791
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-54359
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	162267
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5119
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8875
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181629
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10487
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122151
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181629
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2648
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	40770
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1294
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	803
CY2021	us-gaap	Interest Paid Net InterestPaidNet	480578
CY2020	us-gaap	Interest Paid Net InterestPaidNet	266018
CY2021Q4	us-gaap	Area Of Land AreaOfLand	44000
CY2020	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2021	cbdy	Warrants Purchase WarrantsPurchase	7211213
CY2021	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2021Q4	cbdy	Settlement Liabilities Current And Noncurrent SettlementLiabilitiesCurrentAndNoncurrent	10000
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	10000
CY2020Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	90000
CY2020Q4	cbdy	Settlement Liabilities Non Current SettlementLiabilitiesNonCurrent	10000
CY2021Q4	cbdy	Allowance On Value Added Tax Recoverable AllowanceOnValueAddedTaxRecoverable	509
CY2020Q4	cbdy	Allowance On Value Added Tax Recoverable AllowanceOnValueAddedTaxRecoverable	19924
CY2021Q4	cbdy	Working Capital Deficit WorkingCapitalDeficit	3459035
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26263614
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">USE OF ESTIMATES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2021	cbdy	Revenue From Investments In Joint Venture RevenueFromInvestmentsInJointVenture	2198592
CY2020	cbdy	Revenue From Investments In Joint Venture RevenueFromInvestmentsInJointVenture	108930
CY2021	cbdy	Contract With Customer Liability Increase Decrease For Settlement ContractWithCustomerLiabilityIncreaseDecreaseForSettlement	27500
CY2021	cbdy	Gain From Settlement Of Contract With Customer Liability GainFromSettlementOfContractWithCustomerLiability	15219
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	0
CY2021	cbdy	Foreign Currency Translation ForeignCurrencyTranslation	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">FOREIGN CURRENCY TRANSLATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The functional currency of the Company’s Canadian-based subsidiary is the Canadian dollar, and the US-based parent is the U.S. dollar. In addition, effective April 1, 2019, the Company changed its functional currency from United States Dollar to Canadian Dollar thereby having an impact on additional paid-in capital and accumulated comprehensive income (loss). The presentation currency of the Company has remained unchanged at United States Dollar. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities are translated using the historical rate on the date of the transaction. All exchange gains or losses arising from the translation of these foreign currency transactions are included in net income (loss) for the year. In translating the consolidated financial statements of the Company and its Canadian subsidiaries from their functional currency into the Company’s reporting currency of United States dollars, balance sheet accounts are translated using the closing exchange rate in effect at the balance sheet date and income and expense accounts are translated using an average exchange rate prevailing during the reporting period. Adjustments resulting from the translation, if any, are included in cumulative other comprehensive income (loss) in stockholders’ equity. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.</p>
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44567
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	46775
CY2021Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	4830446
CY2021Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	3810256
CY2021Q4	us-gaap	Inventory Net InventoryNet	99000
CY2020Q4	us-gaap	Inventory Net InventoryNet	99000
CY2021Q4	cbdy	Inventory Pledged As Collateral InventoryPledgedAsCollateral	99000
CY2020Q4	cbdy	Inventory Pledged As Collateral InventoryPledgedAsCollateral	99000
CY2017Q3	us-gaap	Area Of Land AreaOfLand	44000
CY2019Q2	us-gaap	Area Of Land AreaOfLand	44000
CY2021	us-gaap	Depreciation Depreciation	904516
CY2020	us-gaap	Depreciation Depreciation	225585
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8738077
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1896307
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6841770
CY2020Q2	cbdy	Loans To Joint Venture Term Of Debt LoansToJointVentureTermOfDebt	P5Y
CY2021	cbdy	Number Of Customers To Whom Revenue Was Sold NumberOfCustomersToWhomRevenueWasSold	10
CY2020	cbdy	Number Of Customers To Whom Revenue Was Sold NumberOfCustomersToWhomRevenueWasSold	1
CY2020Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	1068910
CY2020Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	839522
CY2021Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	6020535
CY2021Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	4748998
CY2020Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	1735444
CY2020Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	1363018
CY2021Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-1190089
CY2021Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-938742
CY2020Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-666534
CY2020Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-523496
CY2021	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2021	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	30407412
CY2021	cbdy	Warrants Purchase WarrantsPurchase	7211213
CY2020	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2885909
CY2021Q4	cbdy	Accrued Customer Advance For Sales AccruedCustomerAdvanceForSales	394400
CY2021Q4	cbdy	Accrued Consulting And Construction Services AccruedConsultingAndConstructionServices	163101
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	952376
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	973017
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1809120
CY2020Q4	cbdy	Accrued Consulting And Construction Services AccruedConsultingAndConstructionServices	141935
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	403865
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1002098
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	601641
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2141303
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3002127
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2616209
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	8361280
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	601641
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7759639
CY2020Q3	cbdy	Debt Issuance Costs DebtIssuanceCosts	264635
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	191567
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	52927
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	138640
CY2021Q4	cbdy	Accrued Interest Converted Into Principal AccruedInterestConvertedIntoPrincipal	110032
CY2021Q4	cbdy	Accrued Interest Converted Into Principal AccruedInterestConvertedIntoPrincipal	136380
CY2021	us-gaap	Line Of Credit Facility Periodic Payment Interest LineOfCreditFacilityPeriodicPaymentInterest	528848
CY2021	us-gaap	Line Of Credit Facility Periodic Payment Interest LineOfCreditFacilityPeriodicPaymentInterest	670447
CY2021Q4	cbdy	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	320100
CY2021Q4	cbdy	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	405806
CY2021	cbdy	Number Of Operating Lease Facilities NumberOfOperatingLeaseFacilities	2
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.16
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	349340
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	349042
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	344748
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	348195
CY2021Q4	cbdy	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1549937
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2941262
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1311873
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1629389
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	101356
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1528033
CY2021	cbdy	Lessee Operating Lease Reconciliation Schedule LesseeOperatingLeaseReconciliationSchedule	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Below is the reconciliation of the net operating lease presented on the consolidated statement of operations:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">year ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">year ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross operating lease expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 266,757</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 289,083</p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross rent and utilities expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 417,157</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270,366</p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Recoverable expenses from JVCo related to rent and utilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (682,153)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (429,269)</p></td></tr><tr><td style="vertical-align:bottom;width:66.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,761</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,180</p></td></tr></table>
CY2021	cbdy	Gross Operating Lease Expense GrossOperatingLeaseExpense	266757
CY2020	cbdy	Gross Operating Lease Expense GrossOperatingLeaseExpense	289083
CY2021	cbdy	Gross Operating Leases Rent And Utilities Expenses GrossOperatingLeasesRentAndUtilitiesExpenses	417157
CY2020	cbdy	Gross Operating Leases Rent And Utilities Expenses GrossOperatingLeasesRentAndUtilitiesExpenses	270366
CY2021	cbdy	Recoverable Expenses From Jv Co Related To Rent And Utilities RecoverableExpensesFromJvCoRelatedToRentAndUtilities	682153
CY2020	cbdy	Recoverable Expenses From Jv Co Related To Rent And Utilities RecoverableExpensesFromJvCoRelatedToRentAndUtilities	429269
CY2021	cbdy	Operating Lease Expenses Total OperatingLeaseExpensesTotal	1761
CY2020	cbdy	Operating Lease Expenses Total OperatingLeaseExpensesTotal	130180
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	12182
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12068
CY2021	cbdy	Effect Of Conversion Of Convertible Notes EffectOfConversionOfConvertibleNotes	-227
CY2021	cbdy	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-3939
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7902
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	617025999
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	573277094
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	100000000
CY2021	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	100
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	2648
CY2019Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	220000
CY2020Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	3131126
CY2020Q2	cbdy	Common Stock To Be Issued As Consideration Of Intellectual Property Rights Fair Value CommonStockToBeIssuedAsConsiderationOfIntellectualPropertyRightsFairValue	42
CY2020Q3	cbdy	Common Stock To Be Issued As Consideration Of Intellectual Property Rights CommonStockToBeIssuedAsConsiderationOfIntellectualPropertyRights	26040
CY2020Q3	cbdy	Common Stock To Be Issued As Consideration Of Intellectual Property Rights Fair Value CommonStockToBeIssuedAsConsiderationOfIntellectualPropertyRightsFairValue	353
CY2021	cbdy	Schedule Of Shares To Be Issued ScheduleOfSharesToBeIssued	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;width:51.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:51.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 3pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue. 35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:51.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of CannaKorp's loans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:51.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 14 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 124,992</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:51.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:27.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,516,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 174,722</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:51.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td></tr></table>
CY2021	cbdy	Shares To Be Issued SharesToBeIssued	115000
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	73000
CY2021Q4	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2020Q3	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2020Q2	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2020Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0013
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0248
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0013
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0248
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q3	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q2	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.250
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.250
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.02
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.04
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.06
CY2021Q4	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q3	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q2	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q1	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	524
CY2021Q3	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	807
CY2021Q2	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	114211
CY2021Q1	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	2152191
CY2020	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2020Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2020Q2	us-gaap	Share Price SharePrice	0.008
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.200
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.200
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.200
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.93
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.05
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.12
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0027
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0161
CY2020	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2020Q1	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q4	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	545
CY2020Q3	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	132357
CY2020Q2	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	177
CY2020Q1	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	3137
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	350178339
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	364891384
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6146116
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	4978
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-3202271
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2948823
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	3674
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-2930402
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	22095
CY2021	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1469380
CY2021	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1862805
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	11590
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6146116
CY2019Q4	us-gaap	Liabilities Liabilities	12675475
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23699888
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3789021
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	cbdy	Net Income Loss After Adjustment Of New Tax Law NetIncomeLossAfterAdjustmentOfNewTaxLaw	57305
CY2020	cbdy	Net Income Loss After Adjustment Of New Tax Law NetIncomeLossAfterAdjustmentOfNewTaxLaw	-1485513
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	624771
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-32473
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-567466
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1453040
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4067763
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3500297
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4067763
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3500297
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19370301
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16668080
CY2021	cbdy	Operating Loss Expiration Period Description OperatingLossExpirationPeriodDescription	2041
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC

Files In Submission

Name	View Source	Status
0001410578-22-000428-index-headers.html	Edgar Link	pending
0001410578-22-000428-index.html	Edgar Link	pending
0001410578-22-000428.txt	Edgar Link	pending
0001410578-22-000428-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20211231.xsd	Edgar Link	pending
tmb-20211231x10k.htm	Edgar Link	pending
tmb-20211231x10k001.jpg	Edgar Link	pending
tmb-20211231x10k002.jpg	Edgar Link	pending
tmb-20211231x10k_htm.xml	Edgar Link	completed
tmb-20211231xex31d1.htm	Edgar Link	pending
tmb-20211231xex32d1.htm	Edgar Link	pending
tmb-20211231xex3d1.htm	Edgar Link	pending
tmb-20211231_cal.xml	Edgar Link	unprocessable
tmb-20211231_def.xml	Edgar Link	unprocessable
tmb-20211231_lab.xml	Edgar Link	unprocessable
tmb-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBDY
Target Group Inc. Stock $cbdy

2021 Q4 Form 10-K Financial Statement

#000141057822000428 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDY Target Group Inc. Stock $cbdy

2021 Q4 Form 10-K Financial Statement

#000141057822000428 Filed on March 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDY
Target Group Inc. Stock $cbdy